Program & sponsors

Program

Sponsors

Platinum Sponsor

Gold Sponsors

KaliVir is a clinical-stage, science-driven biotechnology company dedicated to pioneering the next-generation oncolytic viral immunotherapy. We harness the unique biology of the vaccinia virus to create optimized, enhanced oncolytic viral backbones for building novel oncolytic vaccinia candidates. Our proprietary Vaccinia Enhanced Template (VETTM) platform employs multiple proprietary genetic modifications that can be combined to generate unique oncolytic vaccinia viruses that are optimized for systemic delivery and expression of therapeutic transgenes within target tumors. We continue to expand our product pipeline using the VETTM platform, and are now advancing multiple therapeutic candidates toward and in the clinic. KaliVir is located in Pittsburgh, Pennsylvania. For more information, visit www.kalivir.com.

Silver Sponsor

Bronze Sponsor

Media sponsor

Rotterdam 2024